BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. World J Gastroenterol 2015; 21(16): 4933-4945 [PMID: 25945007 DOI: 10.3748/wjg.v21.i16.4933]
URL: https://www.wjgnet.com/1007-9327/full/v21/i16/4933.htm
Number Citing Articles
1
Xiaobin Feng, Peipei Song, Ping Bie, Peng Jiang, Kuansheng Ma, Xiaowu Li, Shuguang Wang, Zhigang Wang, Wei Tang, Shuguo Zheng. Des-γ-Carboxyprothrombin Plasma Level in Diagnosis of Hepatocellular Carcinoma in a Chinese Population Undergoing SurgeryMedical Science Monitor 2016; 22: 1663 doi: 10.12659/MSM.895483
2
Jiu Chen, Guolin Wu, Youdi Li. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-AnalysisDisease Markers 2018; 2018: 1 doi: 10.1155/2018/8906023
3
Murtadha M Jawad, Arshad N Aldujaili. Study of the effect of the phenolic extract of the Urtica dioica the level of Des-gamma-prothrombin after treatment with carbon tetrachlorideJournal of Physics: Conference Series 2019; 1294: 062031 doi: 10.1088/1742-6596/1294/6/062031
4
Narongsak Rungsakulkij, Wikran Suragul, Somkit Mingphruedhi, Pongsatorn Tangtawee, Paramin Muangkaew, Suraida Aeesoa. Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resectionInfectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0192-7
5
Hyunyou Kim, So Jeong Lee, Myunghee Yoon. Alpha-fetoprotein is correlated with intrahepatic recurrence of hepatocellular carcinoma after a hepatectomyAnnals of Surgical Treatment and Research 2020; 98(4): 168 doi: 10.4174/astr.2020.98.4.168
6
Mehran Afshar, Peter Fletcher, Antonio D Bardoli, Yuk Ting Ma, Pankaj Punia. Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohortOncotarget 2018; 9(24): 16988 doi: 10.18632/oncotarget.24769
7
Seham A. Omar, Nahla M. Attia, Mohamed I. Sheir, Ayman s. Amer, Mohamed M. EL Shabrawy, Basma B. Hasan. Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation?European Journal of Gastroenterology & Hepatology 2021; 33(7): 1015 doi: 10.1097/MEG.0000000000002074
8
Shin Hwang, Deok-Bog Moon, Ki-Hun Kim, Chul-Soo Ahn, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisJournal of Gastrointestinal Surgery 2020;  doi: 10.1007/s11605-020-04800-6
9
Kei Moriya, Tadashi Namisaki, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Naotaka Shimozato, Yasuhiko Sawada, Akitoshi Douhara, Shinya Sato, Masanori Furukawa, Koh Kitagawa, Takemi Akahane, Hitoshi Yoshiji. Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion ChemotherapyJournal of Clinical Medicine 2021; 10(4): 629 doi: 10.3390/jcm10040629
10
B. N. Kotiv, I. I. Dzidzava, S. A. Alent’yev, A. V. Smorodsky, K. I. Makhmudov, A. A. Apollonov, S. A. Soldatov, P. N. Zubarev. Complex treatment of hepatocellular carcinoma at early (BCLC-A) and intermediate (BCLC-B) stagesAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 55 doi: 10.16931/1995-5464.2020255-66
11
Gil-Chun Park, Shin Hwang, Yo-Han Park, Jin-Uk Choi. Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry DatabaseAnnals of Surgical Treatment and Research 2020; 98(5): 235 doi: 10.4174/astr.2020.98.5.235
12
Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee. Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular CarcinomaJournal of Gastrointestinal Surgery 2016; 20(11): 1807 doi: 10.1007/s11605-016-3187-y
13
Yanying Wang, Ying Qu, XiaoXue Ye, Kangbing Wu, Chunya Li. Fabrication of an electrochemical immunosensor for α-fetoprotein based on a poly-L-lysine-single-walled carbon nanotubes/Prussian blue composite film interfaceJournal of Solid State Electrochemistry 2016; 20(8): 2217 doi: 10.1007/s10008-016-3229-0
14
Jianping Sun, Yanan Zhao, Ling Qin, Kang Li, Yan Zhao, Huanqin Sun, Ting Zhang, Yonghong Zhang. Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative SubtypesFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01069
15
Karim J. Halazun, Marc Najjar, Rita M. Abdelmessih, Benjamin Samstein, Adam D. Griesemer, James V. Guarrera, Tomoaki Kato, Elizabeth C. Verna, Jean C. Emond, Robert S. Brown. Recurrence After Liver Transplantation for Hepatocellular CarcinomaAnnals of Surgery 2017; 265(3): 557 doi: 10.1097/SLA.0000000000001966
16
Xincheng Liu, Yu Huang, Chenglong Jiang, Huohui Ou, Botang Guo, Hui Liao, Xianghong Li, Dinghua Yang. Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinomaDigestive and Liver Disease 2016; 48(8): 953 doi: 10.1016/j.dld.2016.04.015
17
Xin-Xing Hu, Wen-Tao Wang, Li Yang, Zhao-Xia Yang, He-Yue Liang, Ying Ding, Yuan Ji, Meng-Su Zeng, Sheng-Xiang Rao. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomasEuropean Journal of Radiology 2019; 113: 7 doi: 10.1016/j.ejrad.2019.01.036
18
Tatsuya Orimo, Toshiya Kamiyama, Kenji Wakayama, Shingo Shimada, Akihisa Nagatsu, Yoh Asahi, Yuzuru Sakamoto, Hirofumi Kamachi, Akinobu Taketomi. Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched AnalysisAnnals of Surgical Oncology 2020; 27(11): 4153 doi: 10.1245/s10434-020-08754-6
19
Hongbin Zhang, Siyuan Chai, Lintao Chen, Yubizhuo Wang, Yongna Cheng, Quan Fang, Guosen Wu, Xiangming Wang, Wenjie Liang, Wenbo Xiao. MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.611738
20
Tony El Jabbour, Stephen M Lagana, Hwajeong Lee. Update on hepatocellular carcinoma: Pathologists’ reviewWorld Journal of Gastroenterology 2019; 25(14): 1653-1665 doi: 10.3748/wjg.v25.i14.1653
21
Eva Juárez-Hernández, Daniel Motola-Kuba, Norberto Carlos Chávez-Tapia, Misael Uribe, Varenka Barbero Becerra. Biomarkers in hepatocellular carcinoma: an overviewExpert Review of Gastroenterology & Hepatology 2017; 11(6): 549 doi: 10.1080/17474124.2017.1311785
22
Shujing Huang, Feifei Jiang, Ying Wang, Yanhua Yu, Siqian Ren, Xiaowei Wang, Peng Yin, Jinli Lou. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patientsTumor Biology 2017; 39(6): 101042831770576 doi: 10.1177/1010428317705763
23
Xiao-Xiao Ding, Qing-Ge Zhu, Shi-Ming Zhang, Lei Guan, Ting Li, Lei Zhang, Shi-Yang Wang, Wan-Li Ren, Xue-Mei Chen, Jing Zhao, Song Lin, Zhi-Zhen Liu, Yan-Xia Bai, Bing He, Hu-Qin Zhang. Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapyOncotarget 2017; 8(33): 55715 doi: 10.18632/oncotarget.18382
24
Rong Wu, Xiao-Yan Li, Wen-Hai Wang, Fei-Fei Cai, Xiao-Le Chen, Meng-Die Yang, Qiu-Sha Pan, Qi-Long Chen, Rong-Yao Zhou, Shi-Bing Su. Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer TreatmentEvidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/3242989
25
Hao Xing, Cunling Yan, Liming Cheng, Nianyue Wang, Shuyang Dai, Jianyong Yuan, Wenfeng Lu, Zhouchong Wang, Jun Han, Yijie Zheng, Tian Yang. Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinomaTumor Biology 2016; 37(12): 15447 doi: 10.1007/s13277-016-5443-x